Goulburn Valley Health

Shepparton, Victoria 3630

2 studies enrolling now · 13 studies all time

What they study most

Advanced Renal Cell Carcinoma, Breast Cancer, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Cancer, Colorectal Cancer, Early Breast Cancer, HER2-positive Solid Cancers, Malignant Pleural Mesothelioma, Mesothelioma, Metastatic Renal Cell Carcinoma, Non Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer — Recruiting now
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma — Completed
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial — Stopped early
• Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer — Running, not enrolling
• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Study of MT-5111 in HER2-positive Solid Tumors — Stopped early
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed